Skip to main content
OpenTrials
Completed

NCT Number: NCT02540343

Intercultural Adaptation and Validation of the "Orebro Musculoskeletal Pain Questionnaire"

The aim of this study is to adapt and translate the Orebro Musculoskeletal Pain Questionnaire into German.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neck Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Balgrist University Hospital

Zurich, Canton of Zurich, 8008, Switzerland

About this study

Participants will fill out all questionnaires at baseline and again after three days. If the questionnaires have not been returned by day four the participant receives a reminder telephone call. Patients that do not return the questionnaires by day seven are dismissed. The baseline measurement is done at the practice the second measurement will be done by the patient at home. To send the questionnaire back the participant receives a prepaid envelope.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acute:

  • Recently diagnosed with neck pain (< 30 days)
  • Must be able to speak, read and write German

Chronic:

  • Neck problems for a longer period of time (> 90 days)
  • Must be able to speak, read and write German

Healthy volunteers:

  • No neck pain
  • Must be able to speak, read and write German

Exclusion criteria

  • Does not speak, read and write German
  • "Red Flags" e.g. acute trauma
  • Medical knowledge

Treatment and study plan

questionnaires

Other

fill out all questionnaires twice

Primary outcomes

  1. Pain, on the German Version of the Orebro Musculoskeletal Pain Screening Questionnaire

    Time frame: For every patient the average study length is one week.

    Participants are asked to fill out the questionnaire twice. At the start and three to seven days after the first time.

Secondary outcomes

  1. Disability, on the Neck Disability Index (NDI-G)

    Time frame: For every patient the average study length is one week.

    Participants are asked to fill out the questionnaire twice. At the start and three to seven days after the first time.

  2. Pain, on Visual Analogue Pain Rating Scale (VAS)

    Time frame: For every patient the average study length is one week.

    Participants are asked to fill out the questionnaire twice. At the start and three to seven days after the first time.

Other outcomes

  1. Voice Handicap, on the Voice Handicap Index (VHI-9)

    Time frame: For every patient the average study length is one week.

    Participants are asked to fill out the questionnaire twice. At the start and three to seven days after the first time.

  2. Movement restriction, on self-reported measurements of the Range of motion of the cervical spine

    Time frame: For every patient the average study length is one week.

    Participants are asked to fill out the questionnaire twice. At the start and three to seven days after the first time.

Sponsors and collaborators

Lead sponsor

Balgrist University Hospital

Other

Collaborators

  • Maastricht University

Registry information

Official study title

Intercultural Adaptation and Validation of the "Orebro Musculoskeletal Pain Questionnaire"-Translation and Validation of a Questionnaire

Acronym: Orebro-G

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Sep 3, 2015
Registry last updated
Nov 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.